RIGL Stock Analysis: Buy, Sell, or Hold?
RIGL - Rigel Pharmaceuticals Inc. (New)
$36.81
-1.25 (-3.28%)
▼
5d:
+0.19%
30d:
-3.87%
90d:
+27.37%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Get Alerted When RIGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RIGL shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: RIGL shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$74.34
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$46.16
20.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RIGL is currently trading at $36.81, which is considered oversold relative to its 30-day fair value range of $37.40 to $41.52. The stock's valuation (Forward PE: 7.6) is in line with its historical norms (7.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, RIGL is in a strong uptrend. Immediate support is located at $35.01, while resistance sits at $40.64. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $55.20 (+50.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RIGL is in a strong uptrend. Immediate support is located at $35.01, while resistance sits at $40.64. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $55.20 (+50.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$37.40 -
$41.52
Company Quality Score
58/100
(HOLD)
Options IV Signal
11th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
79.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 11th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 50.0% below Wall St target ($55.20)
Trading Range Analysis
30-Day Trading Range
$37.40 -
$41.52
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$5.02
(13.6%)
Support & Resistance Levels
Support Level
$35.01
Resistance Level
$40.64
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.62
Wall Street Target
$55.20
(+50.0%)
Revenue Growth (YoY)
10.3%
Earnings Growth (YoY)
-30.2%
Profit Margin
121.5%
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
7.6 vs 7.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$36.41
(-1%)
2-Year Target
$36.00
(-2%)
3-Year Target
$35.61
(-3%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
$36.93
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 67.0%)
$338.09
(+819%)
Base:
(SPY PE: 7.6, Growth: 67.0%)
$124.23
(+238%)
Bear:
(PE: 6.5, Growth: 67.0%)
$105.60
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 2.02 | Current EPS (TTM): $18.80
Bull Case
$20.93
(-43%)
Analyst growth -50.0%, PE expands to 2.2
Base Case
$19.03
(-48%)
Market implied -50.0%, PE stable at 2.0
Bear Case
$25.88
(-30%)
Severe decline -20.0%, PE contracts to 1.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.6 to 7.9
Stabilization Target:
$38.18
(+3.7%)
PE Expansion Potential:
+3.7%
Share & Embed Analysis
Last updated: August 02, 2026 11:20 PM ET
Data refreshes hourly during market hours. Next update: 12:20 AM
Data refreshes hourly during market hours. Next update: 12:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RIGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Walter H Moos
SELL
4000 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
Advanced RIGL Option Strategies
Professional options setups generated by AI based on today's RIGL price and gamma walls.
